Literature DB >> 16956932

Persistent hepatitis C virus infection in vitro: coevolution of virus and host.

Jin Zhong1, Pablo Gastaminza, Josan Chung, Zania Stamataki, Masanori Isogawa, Guofeng Cheng, Jane A McKeating, Francis V Chisari.   

Abstract

The virological and cellular consequences of persistent hepatitis C virus (HCV) infection have been elusive due to the absence of the requisite experimental systems. Here, we report the establishment and the characteristics of persistent in vitro infection of human hepatoma-derived cells by a recently described HCV genotype 2a infectious molecular clone. Persistent in vitro infection was characterized by the selection of viral variants that displayed accelerated expansion kinetics, higher peak titers, and increased buoyant densities. Sequencing analysis revealed the selection of a single adaptive mutation in the HCV E2 envelope protein that was largely responsible for the variant phenotype. In parallel, as the virus became more aggressive, cells that were resistant to infection emerged, displaying escape mechanisms operative at the level of viral entry, HCV RNA replication, or both. Collectively, these results reveal the existence of coevolutionary events during persistent HCV infection that favor survival of both virus and host.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956932      PMCID: PMC1642175          DOI: 10.1128/JVI.01307-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Authors:  C B Bigger; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells.

Authors:  Bruno Sainz; Francis V Chisari
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.

Authors:  S F Wieland; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  A model for the hepatitis C virus envelope glycoprotein E2.

Authors:  A T Yagnik; A Lahm; A Meola; R M Roccasecca; B B Ercole; A Nicosia; A Tramontano
Journal:  Proteins       Date:  2000-08-15

6.  Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody.

Authors:  W Pumeechockchai; D Bevitt; K Agarwal; T Petropoulou; B C A Langer; B Belohradsky; M F Bassendine; G L Toms
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

7.  Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Authors:  Mayla Hsu; Jie Zhang; Mike Flint; Carine Logvinoff; Cecilia Cheng-Mayer; Charles M Rice; Jane A McKeating
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-21       Impact factor: 11.205

8.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

9.  Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

Authors:  RosaMaria Roccasecca; Helenia Ansuini; Alessandra Vitelli; Annalisa Meola; Elisa Scarselli; Stefano Acali; Monica Pezzanera; Bruno Bruni Ercole; Jane McKeating; Asutosh Yagnik; Armin Lahm; Anna Tramontano; Riccardo Cortese; Alfredo Nicosia
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

View more
  130 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus.

Authors:  Daniel M Jones; Ali M Atoom; Xiaozhen Zhang; Shyamasundaran Kottilil; Rodney S Russell
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.

Authors:  Haihong Zhu; Flossie Wong-Staal; Haekyung Lee; Andrew Syder; Jeffrey McKelvy; Robert T Schooley; David L Wyles
Journal:  J Infect Dis       Date:  2012-02-15       Impact factor: 5.226

4.  The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles.

Authors:  Priyanka Shukla; Kristina N Faulk; Suzanne U Emerson
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

5.  Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.

Authors:  Mark S Sulkowski; Minhee Kang; Roy Matining; David Wyles; Victoria A Johnson; Gene D Morse; Valerianna Amorosa; Debika Bhattacharya; Kristine Coughlin; Flossie Wong-Staal; Marshall J Glesby
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

6.  Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Authors:  Stéphanie B N Serre; Henrik B Krarup; Jens Bukh; Judith M Gottwein
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.

Authors:  Naina Barretto; Bruno Sainz; Snawar Hussain; Susan L Uprichard
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.

Authors:  Urtzi Garaigorta; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

9.  Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.

Authors:  Guaniri Mateu; Ruben O Donis; Takaji Wakita; Jens Bukh; Arash Grakoui
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

10.  Novel function of CD81 in controlling hepatitis C virus replication.

Authors:  Yong-Yuan Zhang; Bai-Hua Zhang; Koji Ishii; T Jake Liang
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.